Literature DB >> 22570497

Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation.

Ciro Coletta1, Andreas Papapetropoulos, Katalin Erdelyi, Gabor Olah, Katalin Módis, Panagiotis Panopoulos, Antonia Asimakopoulou, Domokos Gerö, Iraida Sharina, Emil Martin, Csaba Szabo.   

Abstract

Hydrogen sulfide (H(2)S) is a unique gasotransmitter, with regulatory roles in the cardiovascular, nervous, and immune systems. Some of the vascular actions of H(2)S (stimulation of angiogenesis, relaxation of vascular smooth muscle) resemble those of nitric oxide (NO). Although it was generally assumed that H(2)S and NO exert their effects via separate pathways, the results of the current study show that H(2)S and NO are mutually required to elicit angiogenesis and vasodilatation. Exposure of endothelial cells to H(2)S increases intracellular cyclic guanosine 5'-monophosphate (cGMP) in a NO-dependent manner, and activated protein kinase G (PKG) and its downstream effector, the vasodilator-stimulated phosphoprotein (VASP). Inhibition of endothelial isoform of NO synthase (eNOS) or PKG-I abolishes the H(2)S-stimulated angiogenic response, and attenuated H(2)S-stimulated vasorelaxation, demonstrating the requirement of NO in vascular H(2)S signaling. Conversely, silencing of the H(2)S-producing enzyme cystathionine-γ-lyase abolishes NO-stimulated cGMP accumulation and angiogenesis and attenuates the acetylcholine-induced vasorelaxation, indicating a partial requirement of H(2)S in the vascular activity of NO. The actions of H(2)S and NO converge at cGMP; though H(2)S does not directly activate soluble guanylyl cyclase, it maintains a tonic inhibitory effect on PDE5, thereby delaying the degradation of cGMP. H(2)S also activates PI3K/Akt, and increases eNOS phosphorylation at its activating site S1177. The cooperative action of the two gasotransmitters on increasing and maintaining intracellular cGMP is essential for PKG activation and angiogenesis and vasorelaxation. H(2)S-induced wound healing and microvessel growth in matrigel plugs is suppressed by pharmacological inhibition or genetic ablation of eNOS. Thus, NO and H(2)S are mutually required for the physiological control of vascular function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570497      PMCID: PMC3384190          DOI: 10.1073/pnas.1202916109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.

Authors:  Asif K Mustafa; Gautam Sikka; Sadia K Gazi; Jochen Steppan; Sung M Jung; Anil K Bhunia; Viachaslau M Barodka; Farah K Gazi; Roxanne K Barrow; Rui Wang; L Mario Amzel; Dan E Berkowitz; Solomon H Snyder
Journal:  Circ Res       Date:  2011-10-06       Impact factor: 17.367

Review 2.  Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential.

Authors:  Edward G Lynn; Richard C Austin
Journal:  Expert Rev Clin Pharmacol       Date:  2011-01       Impact factor: 5.045

3.  PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis.

Authors:  Vasiliki Koika; Zongmin Zhou; Ioannis Vasileiadis; Charis Roussos; Federica Finetti; Martina Monti; Lucia Morbidelli; Andreas Papapetropoulos
Journal:  Vascul Pharmacol       Date:  2010-09-08       Impact factor: 5.773

Review 4.  Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease.

Authors:  Joseph Ramli; Pedro CalderonArtero; Robert C Block; Shaker A Mousa
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

5.  Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function.

Authors:  Kunihiro Suzuki; Gabor Olah; Katalin Modis; Ciro Coletta; Gabriella Kulp; Domokos Gerö; Petra Szoleczky; Tuanjie Chang; Zongmin Zhou; Lingyun Wu; Rui Wang; Andreas Papapetropoulos; Csaba Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

Review 6.  Hydrogen sulphide and angiogenesis: mechanisms and applications.

Authors:  Csaba Szabó; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 7.  Hydrogen sulfide and cell signaling.

Authors:  Ling Li; Peter Rose; Philip K Moore
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 8.  Nitric oxide synthases: regulation and function.

Authors:  Ulrich Förstermann; William C Sessa
Journal:  Eur Heart J       Date:  2011-09-01       Impact factor: 29.983

9.  Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity.

Authors:  Mariarosaria Bucci; Andreas Papapetropoulos; Valentina Vellecco; Zongmin Zhou; Anastasia Pyriochou; Charis Roussos; Fiorentina Roviezzo; Vincenzo Brancaleone; Giuseppe Cirino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-15       Impact factor: 8.311

10.  Use of the mouse aortic ring assay to study angiogenesis.

Authors:  Marianne Baker; Stephen D Robinson; Tanguy Lechertier; Paul R Barber; Bernardo Tavora; Gabriela D'Amico; Dylan T Jones; Boris Vojnovic; Kairbaan Hodivala-Dilke
Journal:  Nat Protoc       Date:  2011-12-22       Impact factor: 13.491

View more
  240 in total

Review 1.  Redox regulation of vascular remodeling.

Authors:  Keyvan Karimi Galougahi; Euan A Ashley; Ziad A Ali
Journal:  Cell Mol Life Sci       Date:  2015-10-20       Impact factor: 9.261

Review 2.  Modes of physiologic H2S signaling in the brain and peripheral tissues.

Authors:  Bindu D Paul; Solomon H Snyder
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

Review 3.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 4.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.

Authors:  Csaba Szabo; Céline Ransy; Katalin Módis; Mireille Andriamihaja; Baptiste Murghes; Ciro Coletta; Gabor Olah; Kazunori Yanagi; Frédéric Bouillaud
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 5.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling.

Authors:  Shuai Yuan; Christopher G Kevil
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

Review 6.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

7.  Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway.

Authors:  Yulan Zhen; Qiaomei Wu; Yiqian Ding; Wei Zhang; Yuansheng Zhai; Xiaoxiong Lin; Yunxia Weng; Ruixian Guo; Ying Zhang; Jianqiang Feng; Yiyan Lei; Jingfu Chen
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

Review 8.  Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.

Authors:  David J Polhemus; David J Lefer
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

Review 9.  Hydrogen sulfide and dermatological diseases.

Authors:  Silvia A Coavoy-Sánchez; Soraia K P Costa; Marcelo N Muscará
Journal:  Br J Pharmacol       Date:  2019-06-18       Impact factor: 8.739

10.  Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells.

Authors:  Zhongjian Cheng; Venkata Naga Srikanth Garikipati; Emily Nickoloff; Chunlin Wang; David J Polhemus; Jibin Zhou; Cynthia Benedict; Mohsin Khan; Suresh K Verma; Joseph E Rabinowitz; David Lefer; Raj Kishore
Journal:  Circulation       Date:  2016-09-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.